SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is experiencing intense volatility and a sharp sell-off following a significant double miss on earnings and weak forward guidance. The community is sharply divided between investors arguing that the stock is a deep-value turnaround play given its cash-rich balance sheet and others expressing deep frustration with management, with many actively debating the impact of executive turnover and the company's long-term competitive moat.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending after reporting record quarterly revenue that significantly exceeded analyst expectations, driven by strong commercial execution and improving margins for its cell therapy. Investors are optimistic about management's commentary on the accelerating pipeline, particularly regarding positive signals from lung cancer studies, while the community remains focused on potential upward guidance revisions and the stock's significant short interest.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is surging as investors react to reports of potential U.S. restrictions on Chinese optical transceivers, a move that could significantly boost domestic suppliers of critical AI infrastructure components. The market is also heavily focused on the company's upcoming earnings report, with sentiment driven by expectations for accelerated 800G and 1.6T product growth alongside aggressive manufacturing capacity expansion in Texas.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as investors weigh the impact of recent sector-wide weakness against the company's upcoming earnings report, with community discussion intensely focused on whether strong user growth can offset disappointing revenue and competitive pressure. Investors are actively debating the company's valuation, the long-term potential of its new prediction market offerings, and the broader fallout from competitor earnings.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is drawing significant investor interest as the community braces for an upcoming earnings release, with many traders betting on a short squeeze fueled by high institutional ownership, a significant short interest ratio, and persistent rumors of a potential take-private buyout. While some retail investors are aggressively accumulating shares and calls in anticipation of a turnaround, bears remain skeptical, citing concerns over fast-food market saturation and the potential for dividend sustainability amid the company's global expansion efforts.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital Holdings is facing intense criticism from shareholders and investors who are expressing frustration over stagnant performance, lack of executive accountability, and a shift in business strategy toward AI infrastructure that many view as poorly timed. Market sentiment is heavily impacted by the stock's volatility and its consistent underperformance compared to the broader crypto mining sector, with community members actively discussing a lack of operational execution and leadership concerns as central drivers of the recent price decline.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian is experiencing significant positive momentum following a robust earnings report that highlighted strong cloud revenue growth and effective AI integration, effectively challenging the narrative that AI poses an existential threat to established SaaS platforms. The community is actively debating the stock's recovery potential, with many traders focused on the sharp price appreciation, the prospect of a sustained short squeeze, and the company's ability to maintain its growth trajectory.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group Inc. is currently at the center of intense market speculation as investors await an official decision on the FDA's accelerated approval for its skin cancer candidate, RP1, following a significant delay beyond the PDUFA date. The community is sharply divided, with bulls pointing to a favorable advisory committee vote as a sign of imminent approval, while bears and short-sellers are actively flagging management's silence and the lack of official disclosures as potential signals for a third Complete Response Letter or significant dilution risks.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is trending as investors weigh recent government funding and collaborative partnership news against concerns about the company's financial burn and competitive market position. The community is actively debating the stock's long-term potential in the quantum sector, with discussions focused on technical fidelity milestones versus the challenges of achieving scalable commercial viability.

Doximity, Inc. engages in the development and operation of an online platform for medical professionals. Its cloud-based software has the ability to enable users to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. The company was founded by Shari Buck, Konstantin Guericke, Nate Gross, and Jeffrey A. Tangney on April 16, 2010 and is headquartered in San Francisco, CA.

Doximity Inc - Ordinary Shares - Class A

Doximity Inc

Doximity is experiencing extreme volatility and heavy selling pressure following a revenue guidance miss, leading to intense community debate over whether the sell-off is a justified correction of an overvalued stock or a temporary overreaction. Traders are actively discussing the possibility of a short squeeze or a bargain-buying opportunity, while many express frustration over the divergence between the company's earnings beat and the negative market response.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Inogen Announces Second Quarter 2026 Financial Results

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended June 30, 2026. Our second quarter results demonstrate continued demand for our products and validate the...

Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report second quarter 2026 financial results after the market closes on Thursday, August 6, 2026. On the same day, the Company will host a...

Inogen Announces the Appointment of Andy Reding as Chief Operating Officer

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Andy Reding to the newly created role of Chief Operating Officer, effective Monday, July 6, 2026. Mr. Reding will be responsible for...

Here's Why You Should Retain Inogen Stock in Your Portfolio for Now

INGN's POC strength, expanding respiratory portfolio and international momentum support growth, though U.S. revenue pressure remains a key risk.

INGN broadens beyond portable oxygen concentrators into home respiratory care, but U.S. revenues face pressure from channel shifts.

INGN Stock Dips on Q1 Earnings Miss, Sales Up Y/Y, Gross Margin Improves

Inogen posts higher Q1 revenues and improved gross margin as international portable oxygen demand offsets weaker U.S. sales.

Inogen (INGN) Q1 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Inogen (INGN) Reports Q1 Loss, Beats Revenue Estimates

Inogen (INGN) delivered earnings and revenue surprises of -25.00% and +3.29%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Inogen Announces First Quarter 2026 Financial Results

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended March 31, 2026 and reiterated its full-year guidance. Our first quarter revenue exceeded our outlook with...

Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates

Neuronetics (STIM) delivered earnings and revenue surprises of +5.88% and +0.60%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

$INGN Q2 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of -$0.14 up 6.67% YoY
• Reported revenue of $95.08M up 3.04% YoY
• Inogen now expects full year 2026 reported revenue in the range of $355 million to $361 million and adjusted EBITDA of approximately $4.0 million, representing a 48.1% increase from 2025.

Stocktwits

Inogen Inc

 Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.14 up 6.67% YoY
• Reported revenue of $95.08M up 3.04% YoY
• Inogen now expects full year 2026 reported revenue in the range of $355 million to $361 million and adjusted EBITDA of approximately $4.0 million, representing a 48.1% increase from 2025.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

$INGN Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.14 up 6.67% YoY
• Reported revenue of $95.08M up 3.04% YoY
• Inogen now expects full year 2026 reported revenue in the range of $355 million to $361 million and adjusted EBITDA of approximately $4.0 million, representing a 48.1% increase from 2025.

Inogen, Inc. is a global medical technology company offering innovative respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class respiratory therapy devices used to deliver care to patients suffering from chronic respiratory conditions. Its products include Inogen One G4 system, Inogen One G3 system, Inogen One G5 system, Inogen TAV, and Inogen at Home. The company was founded by Alison Perry, Alison K. Bauerlein, Brenton Taylor, and Byron Myers on November 27, 2001 and is headquartered in Beverly, MA.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info